Role of green tea catechins in prevention of age‐related cognitive decline: Pharmacological targets and clinical perspective. Issue 3 (6th September 2018)

• Record Type: Journal Article
• Authors: Farzaei, Mohammad Hosein; Bahramsoltani, Roodabeh; Abbasabadi, Zahra; Braidy, Nady; Nabavi, Seyed Mohammad
• Is Part Of: Journal of cellular physiology. Volume 234:Issue 3(2019:Mar.)
• Page Start: 2447
• Page End: 2459
• Publication Date: 2018-09-06
• Subjects: Alzheimer disease -- catechins -- cognitive decline -- dementia -- green tea -- neurodegenerative disease -- phenolic compounds -- polyphenols; Physiology -- Periodicals; Cell physiology -- Periodicals; 571.6
• DOI: 10.1002/jcp.27289
• Languages: English
• ISSNs: 0021-9541

Abstract

Abstract: Over the past decade, a wide range of scientific investigations have been performed to reveal neuropathological aspects of cognitive disorders; however, only limited therapeutic approaches currently exist. The failures of conventional therapeutic options as well as the predicted dramatic rise in the prevalence of cognitive decline in the coming future show the necessity for novel therapeutic agents. Recently, a wide range of research has focused on pharmacological activities of green tea catechins worldwide. Current investigations have clarified mechanistic effects of the catechins in inflammatory cascades, oxidative damages, different cellular transcription as well as transduction pathway in various body systems. It has been demonstrated that green tea polyphenols prevent age‐related neurodegeneration through improvement of endogenous antioxidant defense mechanisms, modulation of neural growth factors, attenuation of neuroinflammatory pathway, and regulation of apoptosis. The catechins exhibited beneficial effects in cellular and animal models of neurodegenerative diseases including Alzheimer's disease, MS, and Parkinson's disease. The present review discusses the current pharmacological targets, which can be involved in the treatment of cognitive decline and addresses the action of catechin derivatives elicited from green tea on the multiple neural targets. Abstract : The failures of conventional therapeutic options as well as the predicted dramatic rise in the prevalence of cognitive decline in the coming future show the necessity for novel therapeutic agents. It is been demonstrated that green tea polyphenols prevent age‐related neurodegeneration through improvement of endogenous antioxidant defense mechanisms, modulation of neural growth factors, attenuation of neuroinflammatory pathway, and regulation of apoptosis. The present review discusses the current pharmacological targets, which can be involved in treatment of cognitive decline and addresses the action of catechin derivatives elicited from green tea on the multiple neural targets.